Skip to content

CROI: Atazanavir/ritonavir joins other boosted PIs as potential single-class maintenance regimen

CROI: Rapid scale-up of HIV treatment in Zambia

CROI: 70% still on first regimen after three years in Khayelitsha, but lactic acidosis a major challenge

CROI: Insulin resistance common in HIV-positive children

CROI: Simplified treatment regimens show promise in HIV-infected children

Experimental HCV protease inhibitor to receive fast track approval

Statins may not affect CD4 cell count responses to HIV treatment, study suggests

Prevalence of UK HIV drug resistance in antiretroviral-naive falls to 9%

Once-daily arm in maraviroc treatment-naive study terminated